The Efficacy And Safety Of Pembrolizumab In Advanced Cervical Cancer-A Real World Treatment Study In An Irish Healthcare Setting.

e18007Background: Pembrolizumab is a monoclonal antibody that binds to the PD1 receptor blocking its interaction with PDL1 and PDL2, releasing PD1 pathway-mediated inhibition of the immune response...